EditorsAbout the SiteComes vs. MicrosoftUsing This Web SiteSite ArchivesCredibility IndexOOXMLOpenDocumentPatentsNovellNews DigestSite NewsRSS

06.07.10

The Gates Foundation-Connected GlaxoSmithKline Indirectly Paid Scientists to Exaggerate Vaccine Needs

Posted in Bill Gates, Intellectual Monopoly, Patents at 5:15 am by Dr. Roy Schestowitz

GlaxoSmithKline logo

Summary: The philanthrocapitalist establishment whose Head of Global Health comes from GlaxoSmithKline has its work put to great scrutiny

THE Gates Foundation does not get much of a break because more and more people are beginning to understand its interests. It’s more complex than just “charity” as profit is being made without the foundation ever been taxed like a normal investor.

Today we turn our sceptical eye to the issue of patents and how the Gates Foundation promotes them. There is no question about the fact that Africa suffers from deadly diseases and Gates’ endeavours there are mostly commendable [1, 2]. It is a short-term solution which probably works well for both sides.

“The Gates Foundation acts as somewhat of a PR shim that intervenes where patents interfere/intersect with human toll.”What ought to be better understood is Bill Gates’ close relationship and interpersonal ties with the world’s largest pharmaceutical companies, which even work well inside the Gates Foundation (holding key positions). The Gates Foundation acts as somewhat of a PR shim that intervenes where patents interfere/intersect with human toll. It’s a marriage of convenience because the price of life is the route to big profits.

The following new report from The Guardian reveals that flu experts were indirectly being paid by pharmaceutical giants in order to overplay the risk of swine flu and thus increase sales of vaccines. GlaxoSmithKline (GSK) is mentioned among the culprits. [via Richard stallman]

Report condemns swine flu experts’ ties to big pharma

Scientists who drew up the key World Health Organisation guidelines advising governments to stockpile drugs in the event of a flu pandemic had previously been paid by drug companies which stood to profit, according to a report out today.

An investigation by the British Medical Journal and the Bureau of Investigative Journalism, the not-for-profit reporting unit, shows that WHO guidance issued in 2004 was authored by three scientists who had previously received payment for other work from Roche, which makes Tamiflu, and GlaxoSmithKline (GSK), manufacturer of Relenza.

City analysts say that pharmaceutical companies banked more than $7bn (£4.8bn) as governments stockpiled drugs. The issue of transparency has risen to the forefront of public health debate after dramatic predictions last year about a swine flu pandemic did not come true.

GSK was mentioned by us earlier today. We promised to revisit the subject because according to Portfolio.com, not only does the Gates Foundation have staff from GSK but it also has power over GSK:

The Bill & Melinda Gates Foundation was a driving force behind GlaxoSmithKline Plc’s decision to share propietary drug research for fighting malaria, the Puget Sound Business Journal reports.

That’s the same GSK which corrupted science in order to increase sales. That’s the same GSK which brought to the Gates Foundation its Head of Global Health, who bullies researchers. Gates Keepers writes about those patented drugs which the Gates Foundation is promoting:

Read this carefully: “so that all the people who are smart about the disease are to some degree on the same side, working together.” Here is a fatal flaw. Gates thinks that you can define “all the people who are smart about the disease” and invite them to work together. He and his staff wouldn’t know how to begin to find “all the people”. They are elite technocrats. How many people LIVING with the disease are working together on his elite panels?

This whole “parenthood” role which the Gates Foundation has been taking for years is sometimes just a tad insulting (patronising even) and it marginalises opposing/alternative points of view. Researchers often complain about that. Here is someone who is challenging their priorities:

Gates really, really likes the idea of using vertical funds to tackle (and eliminated) diseases one by one, rather than taking a more gradual, measured approach. Why do the big philanthropists (Gates, and by proxy, Buffet) prefer to take such a direct approach, circumventing governments?

The easiest explanation is through personality or experience: Gates is an entrepreneur, used to getting smart people in a room together to solve problems; private solutions for important problems. Governments have, if anything, been a source of irritation for him, lobbing the occasional anti-trust action at Microsoft.

[...]

I think it’s probably unrealistic to expect the Gates Foundation to start up a health SWAp anytime soon – the same factors that led to its creation will always drive it to tackle problems the way it does. What we should hope (and push) for is a commitment to “do no harm.” This means reverting to practices that do not distort health objectives on the ground (i.e. internal brain drain of qualified health staff, shifting the debate away from enforcing health systems to tackling single diseases). Working on vaccines, either through direct funding or advance market commitments, is a an example of high risk but less distortionary practice. The huge sums of money the Foundation juggles could also be used to create incentives for more general research into fighting tropical maladies, and then subsequently subsidise the price for needy countries.

Here is another new example from NYTimes.com. It’s very relevant to the above example.

“iBio and Fraunhofer USA Center for Molecular Biotechnology Enter Agreement to Provide Global Access for Bill & Melinda Gates Foundation Vaccines,” says the title of this new press release.

iBio, Inc. and the Fraunhofer USA Center for Molecular Biotechnology (CMB) announced today an agreement which provides a license of iBio’s proprietary technology to CMB for the development and manufacture of Global Health Vaccines for, and financed by, the Bill & Melinda Gates Foundation.

To avoid misunderstandings, the problem here is not vaccinations. Immunology and drugs are important and often vital for the saving of lives, but the economics here are a tricky operation that leaves the public out in the dark. The drugs industry is not just another industry like IT. The drug industry is massive and that’s where the big money is. Gates has investments in this industry, so it’s in his interest to promote it. Another related area is biotechnology, where Monsanto got itself a nice monopoly on the food chain. “Bill Gates reveals support for GMO eg,” says this headline from last year (one that we’ve just found and missed at the time, even though we already quite knowingly stated the facts [1, 2, 3, 4, 5, 6, 7, 8]).

As it has come to dominate the agenda for reshaping African agriculture over the years, the Bill and Melinda Gates Foundation has been very careful not to associate itself too closely with patent-protected biotechnology as a panacea for African farmers.

True, the foundation named 25-year Monsanto veteran Rob Horsch to the position of “senior program officer, focusing on improving crop yields in sub-Saharan Africa.”

Yet its flagship program for African ag, the Alliance for a Green Revolution in Africa (AGRA), explicitly distances itself from GMOs. “AGRA does not fund the development of GMOs,” the organization’s Web site states.

But AGRA — co-funded by the Rockefeller Foundation, proud sponsor of the original Green Revolution — is just part of what Gates does around African ag. What precisely is the foundation getting up to over there? Is it pushing GMOs on African smallholder farms?

Earlier on we wrote about GSK inside the Gates Foundation (Head of Global Health), but what many people overlook is that fact that there are Monsanto employees inside the Gates Foundation. They use the Gates Foundation as a seemingly ‘charitable’ lobby vehicle through which to advance the companies’ objectives, often at the expense of the public (which pays government tax to be funneled into patents on drugs for the developing world). It’s a simple matter of economics, creating scarcity with patents while profiting from massive tax-free investments.

There is another couple of new articles worth paying attention to:

Critics castigate Gastes Foundation on policy demands; India launches native H1N1 vaccines;

[...]

While the Gates Foundation has been widely lauded for its work on a wide range of initiatives, including financing research on new vaccines to guard against common killers in developing nations, some critics have emerged to caution against the foundation’s demands to “toe the line” on its position in policy debates.

Watch another man from the Gates Foundation offering “farming aid” (possibly a veiled reference to GMO):

Prior to joining the Obama Administration, Shah served as director of Agricultural Development in the Global Development Program at the Bill and Melinda Gates Foundation. In his seven years with the Gates Foundation, Shah served as the Foundation’s director of Strategic Opportunities and as deputy director of policy and finance for the Global Health Program.

They are getting increasingly connected to politics. Last week in The Times of India:

Obama appoints Indian-American to head U.S National Science Foundation

[...]

Clinton has Rajiv Shah, a former Gates Foundation executive and health expert, heading the USAID.

Clinton is connected to Bill Gates in ways that we explained before. When it comes to the Gates Foundation, former staff is often pursuing similar agendas after departure. To quote this new press release:

Academic Pharmacy Continues to Expand its Horizons at 2010 AACP Annual Meeting

[...]

He was the first business executive to serve as a public school superintendent and was the first executive director for the Bill & Melinda Gates Foundation.

This probably brings us to the subject of our next post, which says more about Gates Foundation influence on public schools [1, 2, 3, 4, 5].

Share this post: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Reddit
  • co.mments
  • DZone
  • email
  • Google Bookmarks
  • LinkedIn
  • NewsVine
  • Print
  • Technorati
  • TwitThis
  • Facebook

If you liked this post, consider subscribing to the RSS feed or join us now at the IRC channels.

Pages that cross-reference this one

What Else is New


  1. The Linux Foundation is Not About Linux

    Linux Foundation (LF) objectives/missions do not resemble what the Open Source Development Labs, Inc. (OSDL) was founded to accomplish; this puts at grave threat the very raison d'être of both GNU and Linux



  2. Guest Post: The Linux Foundation Needs to Define “Support”

    Part of an ongoing series of articles we do about the Linux Foundation



  3. Dimitris Xenos on Unconstitutional Supranational Arrangements for Patent Law: Leaving Out the Elected Legislators and the People’s Participatory Rights

    A new paper from a British scholar proves to be timely because of the EPO's violations of the European Patent Convention (EPC) and failed push to force-feed Europe with the unconstitutional Unified Patent Court (UPC)



  4. The Campinos-Battistelli Strategy is Working: Patent Trolls Are Coming to Europe!

    It cannot be any less obvious that today's European Patent Organisation (and Office) works for patent offices and for those who pay these patent offices (law firms) rather than for science, technology and the public (including the European public)



  5. Links 25/3/2019: Linux 5.1 RC2, Nano 4.0, PyPy 7.1

    Links for the day



  6. Links 24/3/2019: Microsoft Does Not Change; Lots of FOSS Leftovers

    Links for the day



  7. Just Published: Irrational Ignorance at the Patent Office

    Iancu and his fellow Trump-appointed "swamp" at the USPTO are urged to consult academics rather than law firms in order to improve patent quality in the United States



  8. Microsoft Paid the Open Source Initiative. Now (a Year Later) Microsoft is in the Board of the Open Source Initiative.

    The progression of Microsoft entryism in FOSS-centric institutions (while buying key "assets" such as GitHub) isn't indicative of FOSS "winning" but of FOSS being infiltrated (to be undermined)



  9. Jim Zemlin's Linux Foundation Still Does Not Care About Linux Desktops

    We are saddened to see that the largest body associated with Linux (the kernel and more) is not really eager to see GNU/Linux success; it's mostly concerned about its bottom line (about $100,000,000 per annum)



  10. Links 23/3/2019: Falkon 3.1.0 and Tails 3.13.1

    Links for the day



  11. The Unified Patent Court is Dead, But Doubts Remain Over the EPO's Appeal Boards' Ability to Rule Independently Against Patents on Nature and Code

    Patents used to cover physical inventions (such as engines); nowadays this just isn't the case anymore and judges who can clarify these questions lack the freedom to think outside the box (and disobey patent maximalists' dogma)



  12. Patent Law Firms Still Desperate to Find New Ways to Resurrect Dead Software Patents in the United States

    There's no rebound and no profound changes that favour software patents; in fact, judging by caselaw, there's nothing even remotely like that



  13. Links 22/3/2019: Libinput 1.13 RC2 and Facebook's Latest Security Scandal

    Links for the day



  14. Why the UK Intellectual Property Office (UK-IPO) Cannot Ignore Judges, Whereas the EPO Can (and Does)

    The European Patent Convention (EPC) ceased to matter, judges' interpretation of it no longer matters either; the EPO exploits this to grant hundreds of thousands of dodgy software patents, then trumpet "growth"



  15. The European Patent Office Needs to Put Lives Before Profits

    Patents that pertain to health have always posed an ethical dilemma; the EPO apparently tackled this dilemma by altogether ignoring the rights and needs of patients (in favour of large corporations that benefit financially from poor people's mortality)



  16. “Criminal Organisation”

    Brazil's ex-President, Temer, is arrested (like other former presidents of Brazil); will the EPO's ex-President Battistelli ever be arrested (now that he lacks diplomatic immunity and hides at CEIPI)?



  17. Links 21/3/2019: Wayland 1.17.0, Samba 4.10.0, OpenShot 2.4.4 and Zorin Beta

    Links for the day



  18. Team UPC (Unitary Patent) is a Headless Chicken

    Team UPC's propaganda about the Unified Patent Court (UPC) has become so ridiculous that the pertinent firms do not wish to be identified



  19. António Campinos Makes Up Claims About Patent Quality, Only to be Rebutted by Examiners, Union (Anyone But the 'Puff Pieces' Industry)

    Battistelli's propagandistic style and self-serving 'studies' carry on; the notion of patent quality has been totally discarded and is nowadays lied about as facts get 'manufactured', then disseminated internally and externally



  20. Links 20/3/2019: Google Announces ‘Stadia’, Tails 3.13

    Links for the day



  21. CEN and CENELEC Agreement With the EPO Shows That It's Definitely the European Commission's 'Department'

    With headlines such as “EPO to collaborate on raising SEP awareness” it is clear to see that the Office lacks impartiality and the European Commission cannot pretend that the EPO is “dafür bin ich nicht zuständig” or “da kenne ich mich nicht aus”



  22. Decisions Made Inside the European Patent Organisation (EPO) Lack Credibility Because Examiners and Judges Lack Independence

    The lawless, merciless, Mafia-like culture left by Battistelli continues to haunt judges and examiners; how can one ever trust the Office (or the Organisation at large) to deliver true justice in adherence or compliance with the EPC?



  23. Team UPC Buries Its Credibility Deeper in the Grave

    The three Frenchmen at the top do not mention the UPC anymore; but those who promote it for a living (because they gambled on leveraging it for litigation galore) aren't giving up and in the process they perpetuate falsehoods



  24. The EPO Has Sadly Taken a Side and It's the Patent Trolls' Side

    Abandoning the whole rationale behind patents, the Office now led for almost a year by António Campinos prioritises neither science nor technology; it's all about granting as many patents (European monopolies) as possible for legal activity (applications, litigation and so on)



  25. Where the USPTO Stands on the Subject of Abstract Software Patents

    Not much is changing as we approach Easter and software patents are still fool's gold in the United States, no matter if they get granted or not



  26. Links 19/3/2019: Jetson/JetBot, Linux 5.0.3, Kodi Foundation Joins The Linux Foundation, and Firefox 66

    Links for the day



  27. Links 18/3/2019: Solus 4, Linux 5.1 RC1, Mesa 18.3.5, OSI Individual Member Election Won by Microsoft

    Links for the day



  28. Microsoft and Its Patent Trolls Continue Their Patent War, Including the War on Linux

    Microsoft is still preying on GNU/Linux using patents, notably software patents; it wants billions of dollars served on a silver platter in spite of claims that it reached a “truce” by joining the Open Invention Network and joining the LOT Network



  29. Director Iancu Generally Viewed as a Lapdog of Patent Trolls

    As Director of the Office, Mr. Iancu, a Trump appointee, not only fails to curb patent trolls; he actively defends them and he lowers barriers in order to better equip them with bogus patents that courts would reject (if the targets of extortion could afford a day in court)



  30. Links 17/3/2019: Google Console and IBM-Red Hat Merger Delay?

    Links for the day


CoPilotCo

RSS 64x64RSS Feed: subscribe to the RSS feed for regular updates

Home iconSite Wiki: You can improve this site by helping the extension of the site's content

Home iconSite Home: Background about the site and some key features in the front page

Chat iconIRC Channel: Come and chat with us in real time

CoPilotCo

Recent Posts